Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials
Cannabis Law Report
OCTOBER 6, 2021
(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. Forward-looking statements are only predictions.
Let's personalize your content